Form D · Pharmaceuticals
WATSON PHARMACEUTICALS INC
Corona, CA · CIK 0000884629
Offering snapshot reported Dec 10, 2009 · SEC filing
- Reported sold
- $500M Offering amount: $500M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 2, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2009 | Initial | $500,000,000 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-88462-9A
Source: Form D, filed Dec 10, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul M. Bisaro | Director, Executive |
| Christopher W. Bodine | Director |
| David A. Buchen | Executive |
| Michael J. Fedida | Director |
| Michel J. Feldman | Director |
| Albert F. Hummel | Director |
| R. Todd Joyce | Executive |
| Catherine M. Klema | Director |
| Jack Michelson | Director |
| Anthony Tabatznik | Director |
| Ronald R. Taylor | Director |
| Andrew L. Turner | Director |
| Fred G. Weiss | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
311 Bonnie Circle
Corona, CA, 92880
Corona, CA, 92880